FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE

The Innovation Office
InnovationMarketing@Moffitt.org
(813) 745-6828

20MB052N ACT: Inhibition Of Kir2Dl2 for the Enhancement of Adoptive Immunotherapy